As summarized in review papers, clinical studies found that NFTs appeared following amyloid deposition in Down syndrome (carrying an extra copy of APP) and an increase in CSF tau following amyloid deposition in early onset cases with inherited mutations of APP and presenilin. The gene discussed is APP; the disease is Down syndrome.